Provided herein are engineered decarboxylase polypeptides that are useful for catalyzing the decarboxylation of amino acids such as L-tyrosine to produce tyramine or catalyzing the decarboxylation of L-DOPA to produce dopamine. Also provided are the preparation process of engineered decarboxylase polypeptides as well as reaction process under industrial-relevant conditions. The disclosure also provides polynucleotide sequences encoding engineered decarboxylase polypeptides, recombinant host cells capable of expressing engineered decarboxylase polypeptides, and methods of producing tyramine or dopamine using the engineered decarboxylase polypeptides. Compared to the wild type decarboxylase, the engineered polypeptide provided by this disclosure has better activity and/or stability. The use of the engineered polypeptides for the preparation of tyramine or dopamine reduces the production cost and has a good industrial application prospect.

Provided herein are mycelium materials and methods for production thereof. In some embodiments, a mycelium material includes: a cultivated mycelium material including one or more masses of branching hyphae, wherein the one or more masses of branching hyphae may be disrupted and/or a bonding agent may be combined with the cultivated mycelium material. Methods of producing a mycelium material are also provided.

Provided herein are mycelium materials and methods for production thereof. In some embodiments, a mycelium material includes: a cultivated mycelium material including one or more masses of branching hyphae, wherein the one or more masses of branching hyphae may be disrupted and/or a bonding agent may be combined with the cultivated mycelium material. Methods of producing a mycelium material are also provided.

The invention relates to the uses of a new characterized TET protein showed restricted to N-terminus glycine residues exopeptidase. The invention also relates to a method comprising said use of said new characterized TET protein as a N-terminus glycine residues specific exopeptidase. The invention further relates to a support wherein it is immobilized on said new characterized TET protein as a N-terminus glycine residues specific exopeptidase.

A structure adapted to traverse a fluid environment exerting an ambient fluid pressure is provided. The structure includes an elongate body extending from a root to a wingtip and encapsulating at least one interior volume containing an interior fluid exerting an interior fluid pressure that is different from the ambient fluid pressure. A method of retrofitting a structure adapted to traverse a fluid environment exerting an ambient fluid pressure, the structure comprising an elongate body extending from a root to a wingtip and having at least one interior volume is also provided. The method includes sealing the elongate body to encapsulate the at least one interior volume containing an interior fluid; associating at least one valve with the at least one interior volume; and modifying interior fluid content via the at least one valve to produce an interior fluid pressure that is different from the ambient fluid pressure.

A structure adapted to traverse a fluid environment exerting an ambient fluid pressure is provided. The structure includes an elongate body extending from a root to a wingtip and encapsulating at least one interior volume containing an interior fluid exerting an interior fluid pressure that is different from the ambient fluid pressure. A method of retrofitting a structure adapted to traverse a fluid environment exerting an ambient fluid pressure, the structure comprising an elongate body extending from a root to a wingtip and having at least one interior volume is also provided. The method includes sealing the elongate body to encapsulate the at least one interior volume containing an interior fluid; associating at least one valve with the at least one interior volume; and modifying interior fluid content via the at least one valve to produce an interior fluid pressure that is different from the ambient fluid pressure.

A β-1,6-glucanase mutant which is a mutant of β-1,6-glucanase (EC 3.2.1.75), wherein a Glu residue located at a position corresponding to Glu (E)-321 in SEQ ID NO: 1 is substituted by an amino acid residue X or a Glu (E) residue located at a position corresponding to each of Glu (E)-225 and Glu (E)-321 in SEQ ID NO: 1 is substituted by an amino acid residue X, wherein the amino acid residue (X) is selected from the group consisting of Gln (Q), Gly (G), Ala (A), Leu (L), Tyr (Y), Met (M), Ser (S), Asn (N), and His (H); and a method for measuring β-1,6-glucan, including measuring β-1,6-glucan bonded to the mutant.

A 3D printing assembly, system, and method for 3D printing a biomaterial may include a robotic arm end effector and a barrel clamp assembly. The robotic arm end effector is configured to move along one or more axes of movement for 3D printing. The barrel clamp assembly is distally coupled to the robotic arm end effector and includes a barrel clamp arm and a barrel clamp. The barrel clamp arm includes a top end coupled to the robotic arm end effector and a bottom end opposite to the top end. The bottom end is angled forward with respect to the top end. The barrel clamp is coupled to the bottom end of the barrel clamp arm and is configured to receive and clamp against a distal end of a printing syringe barrel for 3D printing.

A 3D printing assembly, system, and method for 3D printing a biomaterial may include a robotic arm end effector and a barrel clamp assembly. The robotic arm end effector is configured to move along one or more axes of movement for 3D printing. The barrel clamp assembly is distally coupled to the robotic arm end effector and includes a barrel clamp arm and a barrel clamp. The barrel clamp arm includes a top end coupled to the robotic arm end effector and a bottom end opposite to the top end. The bottom end is angled forward with respect to the top end. The barrel clamp is coupled to the bottom end of the barrel clamp arm and is configured to receive and clamp against a distal end of a printing syringe barrel for 3D printing.

A method exosome purification and characterization is contemplated, comprising the steps of secondary two-stage tangential ultrafiltration to produce an extracted solution, pretreatment of the extracted solution for characterization, characterization of the extracted solution to detect particle size and concentration, and freeze-drying of the extracted solution. An exosome purification integrated device is also contemplated. Through the disclosed methods and devices, exosomes may be better purified and characterized in a manner that results in high practical value to overcome the problems associated with conventional exosome purification processes on the market today, including tedious purification processes, long durations, and high costs.